Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Paul M Ridker, James Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto, Fernando Civeira, Marcus Flather, Robert J. Glynn, Jean Gregoire, J. Wouter Jukema, Yuri Karpov, John J.P. Kastelein, Wolfgang Koenig, Alberto Lorenzatti, Pravin Manga, Urszula Masiukiewicz, Michael Miller, Arend Mosterd, Jan Murin, Jose C. Nicolau, Steven Nissen, Piotr Ponikowski, Raul D. Santos, Pamela F. Schwartz, Handrean Soran, Harvey White, R. Scott Wright, Michal Vrablik, Carla Yunis, Charles L. Shear, Jean-Claude Tardif

Open source

DOI: 10.1056/nejmoa1701488
Published: 2017-04-20
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1701488,
  title = {Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients},
  author = {Paul M Ridker and James Revkin and Pierre Amarenco and Robert Brunell and Madelyn Curto and Fernando Civeira and Marcus Flather and Robert J. Glynn and Jean Gregoire and J. Wouter Jukema and Yuri Karpov and John J.P. Kastelein and Wolfgang Koenig and Alberto Lorenzatti and Pravin Manga and Urszula Masiukiewicz and Michael Miller and Arend Mosterd and Jan Murin and Jose C. Nicolau and Steven Nissen and Piotr Ponikowski and Raul D. Santos and Pamela F. Schwartz and Handrean Soran and Harvey White and R. Scott Wright and Michal Vrablik and Carla Yunis and Charles L. Shear and Jean-Claude Tardif},
  year = {2017},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa1701488},
  url = {https://doi.org/10.1056/nejmoa1701488}
}

RIS

TY  - JOUR
TI  - Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
AU  - Paul M Ridker
AU  - James Revkin
AU  - Pierre Amarenco
AU  - Robert Brunell
AU  - Madelyn Curto
AU  - Fernando Civeira
AU  - Marcus Flather
AU  - Robert J. Glynn
AU  - Jean Gregoire
AU  - J. Wouter Jukema
AU  - Yuri Karpov
AU  - John J.P. Kastelein
AU  - Wolfgang Koenig
AU  - Alberto Lorenzatti
AU  - Pravin Manga
AU  - Urszula Masiukiewicz
AU  - Michael Miller
AU  - Arend Mosterd
AU  - Jan Murin
AU  - Jose C. Nicolau
AU  - Steven Nissen
AU  - Piotr Ponikowski
AU  - Raul D. Santos
AU  - Pamela F. Schwartz
AU  - Handrean Soran
AU  - Harvey White
AU  - R. Scott Wright
AU  - Michal Vrablik
AU  - Carla Yunis
AU  - Charles L. Shear
AU  - Jean-Claude Tardif
PY  - 2017
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa1701488
UR  - https://doi.org/10.1056/nejmoa1701488
ER  -

APA

Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., Flather, M., Glynn, R. J., Gregoire, J., Jukema, J. W., Karpov, Y., Kastelein, J. J., Koenig, W., Lorenzatti, A., Manga, P., Masiukiewicz, U., Miller, M., Mosterd, A., Murin, J., Nicolau, J. C., Nissen, S., Ponikowski, P., Santos, R. D., Schwartz, P. F., Soran, H., White, H., Wright, R. S., Vrablik, M., Yunis, C., Shear, C. L., & Tardif, J. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1701488

Source records

crossref · retrieved 2026-09-24T19:51:33.459Z